ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,952.47
      0.36%
      US Tech 100
      20,852.00
      0.51%
      Dow Jones
      42,772.75
      -0.16%
      Brent Oil
      71.83
      -1.22%
      Bitcoin
      93,558.34
      -1.61%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Spyre Therapeutics Inc (SYRE) Quote

      Spyre Therapeutics Inc

      Spyre Therapeutics Inc (SYRE)

      NASDAQ
      23.44
      -0.42
      ( -1.76% )
      Updated: 11:48:11
      Delayed by 15 minutes

      Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

      Premium

      Key stats and details

      Current Price
      23.44
      Bid
      23.36
      Ask
      23.45
      Volume
      81,120
      22.79 Day's Range 23.845
      17.83 52 Week Range 47.97
      Market Cap
      1.206B
      Previous Close
      23.86
      Open
      23.74
      Last Trade
      25
      @
      23.44
      Last Trade Time
      11:48:19
      Financial Volume
      $ 1,897,666
      VWAP
      23.3933
      Average Volume (3m)
      534,403
      Shares Outstanding
      51,431,220
      Dividend Yield
      -
      PE Ratio
      -3.57
      Earnings Per Share (EPS)
      -6.59
      Revenue
      886k
      Net Profit
      -338.79M

      About Spyre Therapeutics Inc

      Aeglea BioTherapeutics Inc is a clinical-stage biotechnology company. It designs and develops innovative human enzyme therapeutics for patients with rare genetic diseases and cancer. The company's lead product candidate includes pegzilarginase, a recombinant human Arginase 1 enzyme, which is in an e... Aeglea BioTherapeutics Inc is a clinical-stage biotechnology company. It designs and develops innovative human enzyme therapeutics for patients with rare genetic diseases and cancer. The company's lead product candidate includes pegzilarginase, a recombinant human Arginase 1 enzyme, which is in an early clinical development stage. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.spyre.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -
      Spyre Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker SYRE. The last closing price for Spyre Therapeutics was $23.86. Over the last year, Spyre Therapeutics shares have traded in a share price range of $ 17.83 to $ 47.97.

      Spyre Therapeutics currently has 51,431,220 shares outstanding. The market capitalization of Spyre Therapeutics is $1.23 billion. Spyre Therapeutics has a price to earnings ratio (PE ratio) of -3.57.

      Ask ADVFN Intelligence (AI)

      SYRE Latest News

      More News

      Spyre Therapeutics Added to the Nasdaq Biotechnology Index

      Spyre Therapeutics Added to the Nasdaq Biotechnology Index PR Newswire WALTHAM, Mass., Dec. 18, 2024 WALTHAM, Mass., Dec. 18, 2024 /PRNewswire/ -- Spyre Therapeutics, Inc. (NASDAQ: SYRE), a...

      December 18 2024
      PR Newswire (US)

      Spyre Therapeutics Announces Grants of Inducement Awards

      Spyre Therapeutics Announces Grants of Inducement Awards PR Newswire WALTHAM, Mass., Dec. 2, 2024 WALTHAM, Mass., Dec. 2, 2024 /PRNewswire/ -- Spyre Therapeutics, Inc. (NASDAQ: SYRE) (the...

      December 02 2024
      PR Newswire (US)

      Spyre Therapeutics Announces First Participants Dosed in Phase 1 Trials of Novel Half-life Extended Anti-TL1A Antibodies

      Spyre Therapeutics Announces First Participants Dosed in Phase 1 Trials of Novel Half-life Extended Anti-TL1A Antibodies PR Newswire WALTHAM, Mass., Dec. 2, 2024 Spyre is concurrently advancing...

      December 02 2024
      PR Newswire (US)

      Spyre Therapeutics to Participate in the 7th Annual Evercore ISI HealthCONx Conference

      Spyre Therapeutics to Participate in the 7th Annual Evercore ISI HealthCONx Conference PR Newswire WALTHAM, Mass., Nov. 25, 2024 WALTHAM, Mass., Nov. 25, 2024 /PRNewswire/ -- Spyre Therapeutics...

      November 25 2024
      PR Newswire (US)

      Form 8-K - Current report

      November 19 2024
      Edgar (US Regulatory)

      Form 424B5 - Prospectus [Rule 424(b)(5)]

      November 19 2024
      Edgar (US Regulatory)

      Spyre Therapeutics Announces Pricing of $200 Million Public Offering of Common Stock

      Spyre Therapeutics Announces Pricing of $200 Million Public Offering of Common Stock PR Newswire WALTHAM, Mass., Nov. 18, 2024 WALTHAM, Mass., Nov. 18, 2024 /PRNewswire/ -- Spyre Therapeutics...

      November 18 2024
      PR Newswire (US)

      Form 424B5 - Prospectus [Rule 424(b)(5)]

      November 18 2024
      Edgar (US Regulatory)

      Spyre Therapeutics Announces Proposed Public Offering of its Common Stock and Pre-Funded Warrants

      Spyre Therapeutics Announces Proposed Public Offering of its Common Stock and Pre-Funded Warrants PR Newswire WALTHAM, Mass., Nov. 18, 2024 WALTHAM, Mass., Nov. 18, 2024 /PRNewswire/ -- Spyre...

      November 18 2024
      PR Newswire (US)

      Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]

      November 18 2024
      Edgar (US Regulatory)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.305-1.2844809433623.74525.7722.5768819824.01155673CS
      4-4.82-17.055909412628.2629.0622.5755549025.84214855CS
      12-4.95-17.435716801728.3940.122.5753440329.47113414CS
      26-0.5-2.0885547201323.9440.122.1958311428.06559473CS
      525.3329.431253451118.1147.9717.8352028029.63180904CS
      15612.63116.8362627210.8147.9710.4249469729.35793182CS
      26012.63116.8362627210.8147.9710.4249469729.35793182CS

      SYRE - Frequently Asked Questions (FAQ)

      What is the current Spyre Therapeutics share price?
      The current share price of Spyre Therapeutics is $ 23.44
      How many Spyre Therapeutics shares are in issue?
      Spyre Therapeutics has 51,431,220 shares in issue
      What is the market cap of Spyre Therapeutics?
      The market capitalisation of Spyre Therapeutics is USD 1.23B
      What is the 1 year trading range for Spyre Therapeutics share price?
      Spyre Therapeutics has traded in the range of $ 17.83 to $ 47.97 during the past year
      What is the PE ratio of Spyre Therapeutics?
      The price to earnings ratio of Spyre Therapeutics is -3.57
      What is the cash to sales ratio of Spyre Therapeutics?
      The cash to sales ratio of Spyre Therapeutics is 1.37k
      What is the reporting currency for Spyre Therapeutics?
      Spyre Therapeutics reports financial results in USD
      What is the latest annual turnover for Spyre Therapeutics?
      The latest annual turnover of Spyre Therapeutics is USD 886k
      What is the latest annual profit for Spyre Therapeutics?
      The latest annual profit of Spyre Therapeutics is USD -338.79M
      What is the registered address of Spyre Therapeutics?
      The registered address for Spyre Therapeutics is 1521 CONCORD PIKE, SUITE 201, NEW CASTLE, WILMINGTON, DELAWARE, 19803
      What is the Spyre Therapeutics website address?
      The website address for Spyre Therapeutics is www.spyre.com
      Which industry sector does Spyre Therapeutics operate in?
      Spyre Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      DRCTDirect Digital Holdings Inc
      $ 2.22
      (303.64%)
      		22.11M
      OCCOptical Cable Corporation
      $ 6.719
      (219.95%)
      		12.6M
      RELIReliance Global Group Inc
      $ 3.60
      (200.00%)
      		90.85M
      TRAWTraws Pharma Inc
      $ 13.3512
      (165.96%)
      		24.07M
      RAPTRAPT Therapeutics Inc
      $ 1.5606
      (89.07%)
      		110.8M
      AILEiLearningEngines Inc
      $ 0.2609
      (-70.52%)
      		11.21M
      MGOLMGO Global Inc
      $ 0.43
      (-54.74%)
      		8.45M
      YHCLQR House Inc
      $ 1.1853
      (-32.27%)
      		931.77k
      NVNINVNI Group Ltd
      $ 5.93
      (-30.89%)
      		2.46M
      TNXPTonix Pharmaceuticals Holding Corporation
      $ 0.428001
      (-30.02%)
      		113.57M
      EDBLEdible Garden AG Inc
      $ 0.4205
      (76.90%)
      		318.28M
      RGTIRigetti Computing Inc
      $ 11.35
      (21.13%)
      		166.81M
      TNXPTonix Pharmaceuticals Holding Corporation
      $ 0.428001
      (-30.02%)
      		113.57M
      RAPTRAPT Therapeutics Inc
      $ 1.5606
      (89.07%)
      		110.8M
      RELIReliance Global Group Inc
      $ 3.60
      (200.00%)
      		90.85M

      SYRE Discussion

      View Posts
      Monksdream Monksdream 3 months ago
      SYRE up and down but mostly up
      👍️0
      Monksdream Monksdream 10 months ago
      SYRE new 52=week high
      👍️0

      Your Recent History

      NASDAQ
      SYRE
      Spyre Therapeutics
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads